HER2-low breast cancer could be associated with an increased risk of brain metastasis.

Deniz Can GuvenMehmet Burak KayaBurak FedaiMucahit OzdenHasan Cagri YildirimKemal KosemehmetogluNeyran KertmenOmer DizdarAysegul UnerSercan Aksoy

Published in: International journal of clinical oncology (2021)

In this study, we observed an increased risk of brain metastasis in localized breast cancer patients with HER2-low disease. We think that a high level of vigilance and a low threshold for brain imaging could benefit HER2-low breast cancer patients similar to the patients with HER-positive disease.

Keyphrases

resting state
white matter
functional connectivity
high resolution
cerebral ischemia
multiple sclerosis
mass spectrometry
breast cancer risk